The application of cell and molecular biology techniques has provided new information on the structure and function of the apolipoproteins, enzymes and receptors that mediate lipoprotein transport. The identification of human mutations at the gene level has established the molecular basis for several clinically important dialipoproteinemias and atherosclerosis.